Clinical trialNCT01371838CompletedPhase 3Interventional

A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia

SponsorPfizerEnrollment848Community-Acquired Bacterial PneumoniaLung Infection of Individual Not Recently Hospitalized

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

David Melnick
AstraZeneca
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

43 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China

Research Site
Beijing, China
Research Site
Chengdu, China
Research Site
Guangzhou, China
Research Site
Haikou, China
Research Site
Hangzhou, China
Research Site
Hefei, China
Research Site
Jiangyin, China
Research Site
Nanchang, China
Research Site
Shanghai, China
Research Site
Shenyang, China
Research Site
Shenzhen, China
Research Site
Shijiazhuang, China
Research Site
Wuxi, China

India

Research Site
Bangalore, India
Research Site
Calicut, India
Research Site
Goā, India
Research Site
Hyderabad, India
Research Site
Jaipur, India
Research Site
Lucknow, India
Research Site
Ludhiana, India
Research Site
Mysore, India
Research Site
New Delhi, India
Research Site
Trivandrum, India
Research Site
Varanasi, India
Research Site
Vellore, India

South Korea

Research Site
Anyang-si, South Korea
Research Site
Bucheon-si, South Korea
Research Site
Cheonan-si, South Korea
Research Site
Chuncheon, South Korea
Research Site
Daegu, South Korea
Research Site
Daejeon, South Korea
Research Site
Incheon, South Korea
Research Site
Seoul, South Korea
Research Site
Suwon, South Korea
Research Site
Wŏnju, South Korea

Taiwan

Research Site
Kaohsiung City, Taiwan
Research Site
Keelung, Taiwan
Research Site
Taichung, Taiwan
Research Site
Taipei, Taiwan

Vietnam

Research Site
Can Tho, Vietnam

3 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Dec 2011
Primary completion: 31 May 2013
Completion: 31 May 2013
Last update posted: 6 Sept 2017
Registered enrollment: 848
Registry id: NCT01371838

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.